Association Between Functional Impairment and Medication Burden in Adults with Heart Failure.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
02 2019
Historique:
received: 09 03 2018
revised: 15 09 2018
accepted: 17 09 2018
pubmed: 30 11 2018
medline: 31 1 2020
entrez: 30 11 2018
Statut: ppublish

Résumé

To determine whether the number of medications taken by adults with heart failure (HF) and impairment in activities of daily living (ADL)-a subpopulation in whom the risks of a high medication burden may outweigh the benefits-differs from the number taken by those without impairment in ADLs. Cross-sectional. National Health and Nutrition Examination Survey (NHANES; 2003-2014), a cross-sectional survey that produces national estimates of adults in the United States. Adults aged 50 and older (mean 70) with self-reported HF (N= 947; representing 4.6 million adults with HF in the United States. We assessed ADL impairment and medication count based on self-report. ADL impairment was defined as having difficulty with or being unable to dress, feed oneself, or get in and out of bed. To determine the independent association between ADL impairment and medication count, we performed sequential Poisson multivariable regression analyses. All analyses were cross-sectional in nature and accounted for the complex survey design of NHANES. Mean medication count was 7.2, and 74% of participants were taking 5 or more medications (polypharmacy). In a multivariable model, ADL impairment was not independently associated with medication count. These findings were similar for those with 3 or more hospitalizations in the prior year, declining health status, and cognitive impairment. After adjusting for confounders including comorbidity, we found that adults with HF and ADL impairment take as many medications as those without ADL impairment. This suggests that providers may not sufficiently consider functional impairment when prescribing medications to adults with HF and thus may unnecessarily expose individuals to risk of adverse outcomes. J Am Geriatr Soc 67:284-291, 2019.

Identifiants

pubmed: 30488944
doi: 10.1111/jgs.15654
pmc: PMC6790071
mid: NIHMS1034895
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

284-291

Subventions

Organisme : NIA NIH HHS
ID : L30 AG060521
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG056446
Pays : United States

Informations de copyright

© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Références

JAMA. 2016 Nov 22;316(20):2115-2125
pubmed: 27893129
J Am Geriatr Soc. 2012 Jan;60(1):34-41
pubmed: 22150441
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):396-402
pubmed: 22592753
Arch Intern Med. 2011 Mar 28;171(6):550-6
pubmed: 21444844
Heart Fail Rev. 2012 Sep;17(4-5):589-95
pubmed: 21688185
Arch Gerontol Geriatr. 2015 May-Jun;60(3):464-70
pubmed: 25697060
Circulation. 2013 Oct 15;128(16):1810-52
pubmed: 23741057
Arch Intern Med. 2001 Apr 9;161(7):996-1002
pubmed: 11295963
J Clin Epidemiol. 2004 Mar;57(3):277-83
pubmed: 15066688
JAMA. 2008 Dec 24;300(24):2867-78
pubmed: 19109115
Br J Clin Pharmacol. 2006 Feb;61(2):218-23
pubmed: 16433876
Expert Opin Drug Saf. 2014 Jan;13(1):57-65
pubmed: 24073682
Geriatr Gerontol Int. 2012 Jul;12(3):425-30
pubmed: 22212467
Am J Med. 2011 Feb;124(2):136-43
pubmed: 21295193
Am J Epidemiol. 1998 May 15;147(10):969-77
pubmed: 9596475
J Clin Epidemiol. 2001 Aug;54(8):837-44
pubmed: 11470394
J Health Soc Behav. 1995 Mar;36(1):1-10
pubmed: 7738325
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
J Am Geriatr Soc. 2011 Sep;59(9):1686-91
pubmed: 21883118
Am J Geriatr Pharmacother. 2010 Apr;8(2):146-60
pubmed: 20439064
BMC Health Serv Res. 2015 Jul 23;15:282
pubmed: 26202163
J Gen Intern Med. 2010 Feb;25(2):135-40
pubmed: 19882192
Pharmacoepidemiol Drug Saf. 2011 May;20(5):514-22
pubmed: 21308855
Circulation. 2017 Apr 18;135(16):e894-e918
pubmed: 28336790
Circulation. 2015 Oct 6;132(14):1347-53
pubmed: 26316616
J Clin Epidemiol. 2012 Sep;65(9):989-95
pubmed: 22742913
J Am Coll Cardiol. 2014 Mar 4;63(8):747-62
pubmed: 24291279
Pharmacoepidemiol Drug Saf. 2010 Sep;19(9):901-10
pubmed: 20623513
Am Heart J. 2003 Aug;146(2):250-7
pubmed: 12891192
J Geriatr Cardiol. 2016 Aug;13(8):645-651
pubmed: 27781053
JAMA Intern Med. 2015 May;175(5):827-34
pubmed: 25798731
Am Heart J. 2007 Aug;154(2):260-6
pubmed: 17643574
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):631-3
pubmed: 26487738
Circ Heart Fail. 2015 Mar;8(2):261-7
pubmed: 25717059
Ann Pharmacother. 2012 Sep;46(9):1188-92
pubmed: 22872750
J Am Geriatr Soc. 2014 Dec;62(12):2261-72
pubmed: 25516023
Ann Intern Med. 1987 Aug;107(2):169-73
pubmed: 2886086
J Aging Health. 1989 Feb;1(1):35-49
pubmed: 10293789
Circ Cardiovasc Qual Outcomes. 2016 Jan;9(1):23-30
pubmed: 26715650
Am J Geriatr Pharmacother. 2010 Jun;8(3):215-24
pubmed: 20624611
N Engl J Med. 2007 Mar 15;356(11):1130-9
pubmed: 17360991
J Heart Lung Transplant. 2013 Feb;32(2):157-87
pubmed: 23352391

Auteurs

Parag Goyal (P)

Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, New York.
Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.

Joanna Bryan (J)

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.

Jerard Kneifati-Hayek (J)

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.

Madeline R Sterling (MR)

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.

Samprit Banerjee (S)

Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.

Mathew S Maurer (MS)

Center for Advanced Cardiac Care, Columbia University Medical Center, New York, New York.

Mark S Lachs (MS)

Division of Geriatrics, Department of Medicine, Weill Cornell Medical College, New York, New York.

Monika M Safford (MM)

Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH